InvestorsHub Logo

samsamsamiam

08/28/14 2:04 PM

#75284 RE: elbiatcho1 #75283

He's got some crazy stuff about the Ukraine visit and Bill's role there. the last thing the UKRAINE needs right now is ADVICE from the likes of BILL CHAABAN!!!! Plus he keeps insisting it is proof that FITX already has their license and Bill isn't telling anyone.


To this end, it is not a far stretch to assume logically that Bill Chaaban is actively giving much needed attention and guidance in safe and effective marijuana grow operation practices in Ukraine. Under the partnership with RXNB that possess "patented proprietary, cutting-edge systems in the field of agriculture, applicable to medical marijuana" Bill Chaaban can show many Ukrainian farming facilities the fundamental importance of current Good Manufacturing Practices (cGMP). These guidelines are specifically adhered to under the new MMPR license agreements per Health Canada. Of note, the new partnership role that CEN Biotech has seemingly proclaimed in Ukraine is paramount to the import and export process of marijuana for not only the company, but Canada itself.

CEN appears to be crouched in wait to also infiltrate the US MMJ market through this unique Ukrainian template platform, which will be revealed as the company initiates more contracts in the future.

Notably, CEN Biotech explains on the company's facebook page:

Bill Chaaban met with Yuriy Shramko, Director of Invest Ukraine, The State Agency for Investment and National Projects of Ukraine regarding Medical Marijuana and Hemp. The meeting took place at the Offices of the Parliamentary Committee that oversees the Laws that may impact the Economic Development of Ukraine, which is the Committee that proposes changes to the laws where deemed necessary. Bill Chaaban also spoke in the offices of Sergey Yevtushenko, the Chairman of Ukraine Investment authority and national projects.

Another meeting convened by Bill Chaaban was with Vasil Govriligk , Head of the Society Development Political party & owner of multiple pharmaceutical facilities.

Lastly, a meeting with Mikhail Kaplun, Director of the Office of the Health Ministry of Kiev and Greater Region for the registration of drugs and medical devices was also paramount in the establishment of new laws and drugs for marijuana and hemp production.

These closed door conferences might have investors ponder the obvious focal point of significance; production of marijuana and hemp at a different country; perhaps a satellite company in varying degrees managed by Cen Biotech. Furthermore, the Canadian government has also recently resumed free trade talks with Ukraine to strengthen Kiev's ties with the West), and pave the way for deeper commercial relations.

This significant relationship is twofold; 1) Cen Biotech is able to augment their energy in various European countries and 2) Canada is able to strategically create stronger relationships with Ukraine in hopes of boosting their own import/export economy.

Bill Chaaban explains at the First Annual Weedstock conference:

We would be able to sell 1.32 million pounds marijuana, and once licensed we would be able to import and export product to countries that allow it. We have a market development and research team that is scouring the globe looking at laws for marijuana and hemp worldwide."

Again, it is important to note that Bill Chaaban would not show key interest in Ukraine if indeed no license was approved.